Table 36

ACCF/AHA/AMA-PCPI 2011 HF Measurement Set

MeasureDescriptionCare SettingLevel of Measurement
  • 1. LVEF assessment

Percentage of patients aged ≥18 y with a diagnosis of HF for whom the quantitative or qualitative results of a recent or prior (any time in the past) LVEF assessment is documented within a 12-mo periodOutpatientIndividual practitioner
  • 2. LVEF assessment

Percentage of patients aged ≥18 y with a principal discharge diagnosis of HF with documentation in the hospital record of the results of an LVEF assessment performed either before arrival or during hospitalization, OR documentation in the hospital record that LVEF assessment is planned for after dischargeInpatient
  • Individual practitioner

  • Facility

  • 3. Symptom and activity assessment

Percentage of patient visits for those patients aged ≥18 y with a diagnosis of HF with quantitative results of an evaluation of both current level of activity and clinical symptoms documentedOutpatientIndividual practitioner
  • 4. Symptom management

Percentage of patient visits for those patients aged ≥18 y with a diagnosis of HF and with quantitative results of an evaluation of both level of activity AND clinical symptoms documented in which patient symptoms have improved or remained consistent with treatment goals since last assessment OR patient symptoms have demonstrated clinically important deterioration since last assessment with a documented plan of careOutpatientIndividual practitioner
  • 5. Patient self-care education

Percentage of patients aged ≥18 y with a diagnosis of HF who were provided with self-care education on ≥3 elements of education during ≥1 visits within a 12-mo periodOutpatientIndividual practitioner
  • 6. Beta-blocker therapy for LVSD (outpatient and inpatient setting)

Percentage of patients aged ≥18 y with a diagnosis of HF with a current or prior LVEF <40% who were prescribed beta-blocker therapy with bisoprolol, carvedilol, or sustained-release metoprolol succinate either within a 12-mo period when seen in the outpatient setting or at hospital dischargeInpatient and outpatient
  • Individual practitioner

  • Facility

  • 7. ACE inhibitor or ARB therapy for LVSD (outpatient and inpatient setting)

Percentage of patients aged ≥18 y with a diagnosis of HF with a current or prior LVEF <40% who were prescribed ACE inhibitor or ARB therapy either within a 12-mo period when seen in the outpatient setting or at hospital dischargeInpatient and outpatient
  • Individual practitioner

  • Facility

  • 8. Counseling about ICD implantation for patients with LVSD on combination medical therapy

Percentage of patients aged ≥18 y with a diagnosis of HF with current LVEF ≤35% despite ACE inhibitor/ARB and beta-blocker therapy for at least 3 mo who were counseled about ICD implantation as a treatment option for the prophylaxis of sudden deathOutpatientIndividual practitioner
  • 9. Postdischarge appointment for HF patients

Percentage of patients, regardless of age, discharged from an inpatient facility to ambulatory care or home health care with a principal discharge diagnosis of HF for whom a follow-up appointment was scheduled and documented, including location, date, and time for a follow-up office visit or home health visit (as specified)InpatientFacility

Adapted from Bonow et al. (921).

NB, Regarding test measure no. 8, implantation of ICD must be consistent with published guidelines. This measure is intended to promote counseling only.

  • Refer to the complete measures for comprehensive information, including measure exception.

  • Test measure designated for use in internal quality improvement programs only. These measures are not appropriate for any other purpose (e.g., pay for performance, physician ranking, or public reporting programs).

  • New measure.

    ACCF indicates American College of Cardiology Foundation; ACE, angiotensin-converting enzyme; AHA, American Heart Association; AMA-PCPI, American Medical Association−Physician Consortium for Performance Improvement; ARB, angiotensin-receptor blocker; HF, heart failure; ICD, implantable cardioverter-defibrillator; LVEF, left ventricular ejection fraction; and LVSD, left ventricular systolic dysfunction.